VEA
CALA

Virtus ETF Advisers’s Calithera Biosciences, Inc CALA Stock Holding History

Virtus ETF Advisers’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,058
Closed -$148K – 406
2021
Q1 		$148K Buy
3,058
+54
+2% +$3.14K 0.06% 345
2020
Q4 		$295K Sell
3,004
-12
-0.4% -$1.05K 0.12% 222
2020
Q3 		$208K Sell
3,016
-411
-12% -$35.9K 0.11% 296
2020
Q2 		$362K Buy
+3,427
New +$407K 0.17% 250
2018
Q2 		– Sell
-4,436
Closed -$559K – 278
2018
Q1 		$559K Buy
4,436
+2,353
+113% +$367K 0.49% 108
2017
Q4 		$348K Buy
2,083
+917
+79% +$235K 0.44% 94
2017
Q3 		$367K Buy
1,166
+107
+10% +$33.8K 0.05% 118
2017
Q2 		$315K Buy
+1,059
New +$283K 0.05% 113

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's CALA Position: Q2 2021 in Review

Virtus ETF Advisers sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 3,058 shares — an estimated $148K sold.

Virtus ETF Advisers first reported a position in CALA in Q2 2017 and held it in 8 quarters. The position peaked at $559K in Q1 2018. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Virtus ETF Advisers reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 3,058 Calithera Biosciences, Inc shares in Q2 2021, an estimated $148K.
  • Virtus ETF Advisers first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 8 quarters.
  • Virtus ETF Advisers's Calithera Biosciences, Inc position peaked at $559K in Q1 2018.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Virtus ETF Advisers's 13F filing for Q2 2021, filed 10 Aug 2021.